COMPETITIVE LUMINEX IMMUNOASSAYS FOR THE DETECTION OF ANTIBODIES TO FOOT-AND-MOUTH DISEASE AND VESICULAR STOMATITIS VIRUSES IN MULTIPLE SUSCEPTIBLE HOSTS.

Slides:



Advertisements
Similar presentations
Enzyme Linked Immunosorbent Assay
Advertisements

ELISA Enzyme Linked Immunosorbent Assay. Definitions  Antibodies (also known as immunoglobulins abbreviated Ig) are gamma globulin proteins that are.
Introduction to Immunoassays
Swine Vesicular Disease Porcine Enterovirus Infection.
Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Al Jouf University.
HIV Testing CDC power point edited by M. Myers
DEPARTMENT OF HEALTH RESEARCH INSTITUTE FOR TROPICAL MEDICINE Ebola Reston in the Philippines Catalino S. Demetria, DVM.
Framework for a microbiological risk assessment to assess virus safety of blood products for feed Dr Lourens Heres.
© 2008 ubio. All rights reserved. 1 FOOT-AND-MOUTH DISEASE IMPLEMENTING EFFECTIVE DISEASE CONTROL PROGRAMS AND ROLE OF NSP ANTIBODY TESTING V I Bishor.
Vesicular Stomatitis. Overview Organism Economic Impact Epidemiology Transmission Clinical Signs Diagnosis and Treatment Prevention and Control Actions.
The study on the effect of foot- and-mouth disease virus titer to the result of detected neutralization antibody titer Hog Cholera Research Division Lin.
How Does ELISA Work? By: Ian Lin, Marko Cavar, Justin Chiu & Lily Hou Sep 15, PHM142 Fall.
Picorna and Caliciviruses
The Enzyme Linked Immunosorbent Assay (ELISA).. Capture ELISAs Antigen Capture: In this, more specific approach, a capturing Ab is adsorbed onto the solid.
FMD in Libya Dr Ibrahim Eldaghayes National Center of Animal Health Libya.
Generation of mAbs to FMDV/A and application in a cELISA for the detection of FMDV/A antibodies Dr. M. Yang National Center for Foreign Animal diseases.
John Gray, Sandor Dudas and Stefanie Czub
Immunology. Purpose of the immune system: –Discriminate self from non-self Non-self –Antigens Immunity: –All mechanisms used by the host to protect itself.
Efficacy of foot-and-mouth disease vaccines A22 Iraq 64 and A Malaysia 97 against challenge with a recent South East Asian serotype A field strain in.
Laboratory #2: ELISA Immuno Explorer
BioPlex 2200 HIV Ag-Ab Assay
The ELISA Enzyme-Linked ImmunoSorbent Assay A highly specific and sensitive procedure allowing evaluation of multiple agents for a single serum dilution.
GENE EXPRESSION STUDY ON PROTEIN LEVEL
department < clinical chemistry, microbiology and immunology >
Multiplex analysis of cytokines Russell Garland KWS BioTest
Enzyme Linked Immunosorbent Assay
Enzyme Linked Immunosorbent Assay (ELISA)
Quantum dot-based lab-on-a-bead system for multiplexed detection of free and total prostate-specific antigens in clinical human serum samples  Kristina.
Kweon Chang Hee, Oh Yoon I, Song Jae Young, Lee Kyoung Ki
Complement fixation test
Synthesis and Evaluation of anti-Nonspecific Binding Coating in Microfluidic Devices for ELISA Bioassays Melissa J. Gelwicks.
Mass Spectrometry Vs. Immunoassay
Laboratory Diagnosis of Infectious Diseases
Plaque Forming Unit (PFU)
Rapid Diagnosis of Dengue virus
Immunological Pregnancy Testing
Riley Byrd and Chunlei Su
Comparison of A60 and three glycolipid antigens in an ELISA test for tuberculosis  Nancy Simonney, Jean Michel Molina, Mathieu Molimard, Eric Oksenhendler,
Efficacy of a Foot-and-Mouth Disease inactivated vaccine (AFTOVAXPUR DOE), administered at a 1 mL dose to sheep Claude Hamers.
Comparison of a multiplexed bead-based assay with an immunofluorescence and an enzyme-immuno assay for the assessment of Epstein–Barr virus serologic.
gRAD (generic Rapid Assay Device)
Unit #5C – Clinical Laboratory Testing – Basic Serology/Immunology
HIV Increases HCV Replication in a TGF-β1–Dependent Manner
APPLICATION OF INDIRECT AND AVIDITY ELISAs TO ASSESS ANTI-FMDV ANTIBODIES INDUCED BY VACCINATION IN BUFFALO AND SWINE SERUM SAMPLES F. Mansilla,; J. Sala,
Abdelghani (Abid) Bin-Tarif | FMD Reference Laboratory
Combining rapid diagnostic tests and dried blood spot assays for point-of-care testing of human immunodeficiency virus, hepatitis B and hepatitis C infections.
Unit #5C – Clinical Laboratory Testing – Basic Serology/Immunology
Autoantibody Signature in Human Ductal Pancreatic Adenocarcinoma
DEVELOPMENT OF A NOVEL VNT ASSAY USING QRT-PCR-BASED ENDPOINT ASSESSMENT FOR RAPID DETECTION AND TITRATION OF NEUTRALIZING ANTIBODIES AGAINST FMDV.
Department of Biotechnology University of Malakand, Pakistan
Characterization of FMDV isolates from Sudan collected from outbreaks
Volume 61, Issue 5, Pages (May 2002)
Barsha Thapa, Jemma Wadsworth, Nick J. Knowles and Donald P. King
Epidemiology of Foot and Mouth Disease in Georgia
M. Afzal, M. J. Arshad, M. Hussain, E. Khan, N. Panhwar and A
Development of an IL-6 Assay on MagPlex®-Avidin Microspheres using Rapid IgG Biotinylation and RPE-IgG labeling kits Jim Lazar and Alvydas Ozinskas, Moss,
Wilson Wambi 1, Ronald Ayikobua 2, Gilbert Sunday3
B.F.C. Sampaio, M.S. Macre, L.R. Meireles, H.F. Andrade 
Department of Biotechnology University of Malakand
Antigen-detection ELISA performance versus virus evolution
Enzyme Linked  Immuno sorbent  Assay  
Masaki Nagai, Minoru Hasegawa, Kazuhiko Takehara, Shinichi Sato 
IL-12 affects Dermatophagoides farinae–induced IL-4 production by T cells from pediatric patients with mite-sensitive asthma  Takeshi Noma, MD, PhD, Izumi.
Comparison between CLIA & ELISA
FMDV infection dynamics in cattle in phase II of the study.
Experimental Systems and Methods
Volume 24, Issue 7, Pages (August 2018)
8-2 Immunoassay Techniques
Chapter 17 Topics Phenotypic Genotypic Immunological Method.
Schematic representation of the reactivities of IgM antibodies induced against Gly-Ala repeats of EBNA-1 and against glycine-rich motifs of HCMV antigens,
Presentation transcript:

COMPETITIVE LUMINEX IMMUNOASSAYS FOR THE DETECTION OF ANTIBODIES TO FOOT-AND-MOUTH DISEASE AND VESICULAR STOMATITIS VIRUSES IN MULTIPLE SUSCEPTIBLE HOSTS Charles Nfon, Diana Lusansky, Tim Salo, Melissa Goolia, Ming Yang, Kate Hole, Tom Hunt National Centre For Foreign Animal Disease, Canadian Food Inspection Agency Winnipeg, Manitoba

Introduction FMD and vesicular stomatitis (VS) are clinically indistinguishable in cattle & swine. Laboratory tests are essential to distinguish between the two Competitive ELISAs for FMD and VS exist The cELISAs can easily be converted into competitive Luminex-based immunoassays (cLIAs)

Objective and Rationale Objective: Develop competitive Luminex-based immunoassays (cLIAs) for FMDV and VSV Luminex-based immunoassays compared to ELISAs: are fast (results within 1.5 to 2 h). require less sample volume are relatively more sensitive can be multiplexed (high throughput)

Materials and Methods For FMDV 3ABC: Recombinant 3ABC antigen MagPlex bead set 44 Mouse anti-FMDV 3B monoclonal antibody Negative sera from pigs, cattle and sheep in Canada (FMD-free country) Positive sera from experimentally infected pigs, cattle and sheep

Materials and Methods For VSV New Jersey (VSV-NJ) Recombinant VSV-NJ glycoprotein MagPlex bead set 46 Mouse polyclonal anti- VSV-NJ antibodies Negative sera from pigs and cattle in Canada (VSV-free country) Positive sera from experimentally infected pigs and cattle

Percent inhibition (PI) Competitive Luminex Assay Ag-coated bead MagPlex beads Antigen + Mse Ab PE-anti- MFI 12,000 + Y Percent inhibition (PI) 75 (1-3000/12000)X100 25 (1-9000/12000)x100 3,000 + Y Mse Ab + pos serum Mse Ab + Neg serum 9,000 + Y

Assay performance characteristics for FMDV 3ABC 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 20 40 60 80 100 120 Sensitivity / Specificity Percent inhibition Sensitivity Specificity Neg Pos 20 40 60 80 100 Percent inhibition

FMDV 3ABC cLIA and cELISA are comparable cLIA (cut off = 58) cELISA (cut off = 50) cLIA (cut off = 58) cELISA (cut off = 50) cLIA (cut off = 58) cELISA (cut off = 50)

Summary for cLIA for FMDV 3ABC Successful development of a cLIA for detection of antibodies to FMDV 3ABC in porcine, bovine and ovine serum Sensitivity 90% and specificity 98% Comparable or slightly more sensitive than a cELISA

Assay performance characteristics for VSV – NJ glycoprotein Sensitivity / Specificity Percent inhibition 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 10 20 30 40 50 60 70 80 90 100 Sensitivity Specificity 20 40 60 80 100 Negative Positive Percent inhibition

Antibody response pattern in VSV-NJ infected animals 20 40 60 80 100 1 2 3 4 5 6 7 14 21 28 DPI Percent inhibition Pigs 20 40 60 80 100 1 2 3 4 5 7 9 11 14 21 28 DPI Percent inhibition Cattle

cLIA more sensitive than cELISA for VSV-NJ cLIA (cut off = 21) cELISA (cut off = 40)

Summary for VSV – NJ glycoprotein cLIA Successful development of a cLIA for detection of antibodies to VSV in porcine and bovine serum Sensitivity 93% and specificity 95.4% cFMIA more sensitive than a cELISA

Conclusion Highly sensitive competitive Luminex-based immunoassays for detection of antibodies to FMDV and VSV are feasible These assays can be multiplexed to simultaneously to obtain rapid results for multiple analytes in a single test

Next steps Further validation of the cLIAs Development of a similar assay for VSV-Indiana serotype Combining the 3 cLIAs into a multiplex assay

Acknowledgements NCFAD Animal Care Staff Amber Papineau for technical support Funding provided by CFIA In-kind support provided by BioVet Inc, Canada

THANK YOU

From Luminexcorp.com